HERON THERAPEUTICS, INC. /DE/ Proceeds from Related Party Debt
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Proceeds from Related Party Debt of $50.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2019-02-22
- HERON THERAPEUTICS, INC. /DE/ proceeds from related party debt for the quarter ending 2016-12-31 was $0.00.
- HERON THERAPEUTICS, INC. /DE/ proceeds from related party debt for fiscal 2016 was $50.00M.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month |
|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $50.00M 10-K · filed 2019-02-22 | |
| 2016-09-30 | $50.00M 10-Q · filed 2017-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |